Related Experiment Video

Updated: Jun 21, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

P19ARF inhibits the functions of the HPV16 E7 oncoprotein

Wei Pan1, Abhishek Datta, Guy R Adami

  • 1Center for the Molecular Biology of Oral Diseases, College of Dentistry (M/C 860), University of Illinois at Chicago, 801S Paulina Street, Chicago, IL 60612, USA.

Oncogene
|August 23, 2003
PubMed

Insights

The tumor suppressor ARF inhibits the human papillomavirus (HPV) E7 oncoprotein, blocking its role in cancer development. This finding suggests ARF-based therapies may combat HPV-related tumors.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • High-risk human papillomavirus (HPV) E7 oncoprotein drives cancer by disrupting cell cycle regulation.
  • E7 targets the Rb protein family, promoting DNA replication and S phase entry.
  • Current therapeutic strategies lack effective E7 inhibitors.

Purpose of the Study:

  • To investigate the inhibitory potential of the tumor suppressor ARF against the HPV E7 oncoprotein.
  • To elucidate the molecular mechanisms by which ARF interacts with and affects E7 function.

Main Methods:

  • Assessing ARF's effect on E7 localization within the cell nucleus.
  • Mapping the specific ARF domains required for E7 interaction.
  • Evaluating ARF's impact on E7-induced Rb proteolysis and DNA replication.

Main Results:

  • ARF expression causes E7 to relocalize from the nucleoplasm to the nucleolus.
  • Specific ARF regions, including MDM2-binding sites, are crucial for E7 relocalization.
  • ARF effectively inhibits E7-mediated Rb degradation and E7-induced DNA replication.

Conclusions:

  • ARF acts as a potent inhibitor of the HPV E7 oncoprotein.
  • ARF interferes with key E7 functions essential for viral oncogenesis.
  • ARF or ARF-derived molecules show therapeutic potential for HPV-related cancers.

More Related Videos

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 12, 2014

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...